Nurix Therapeutics, Inc. (NRIX) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $149.39M | +4.9% |
| 2024 | $142.35M | -8.2% |
| 2023 | $155.10M | +37.2% |
| 2022 | $113.06M | -15.9% |
| 2021 | $134.47M | +26.8% |
| 2020 | $106.07M | +98.0% |
| 2019 | $53.57M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $149.39M | +4.9% |
| 2024 | $142.35M | -8.2% |
| 2023 | $155.10M | +37.2% |
| 2022 | $113.06M | -15.9% |
| 2021 | $134.47M | +26.8% |
| 2020 | $106.07M | +98.0% |
| 2019 | $53.57M | — |